APA (7th ed.) Citation

Barlesi, F., Gorvel, L., Olive, D., Demerle, C., Greillier, L., Pastor, S., . . . Luche, H. (2023). Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Barlesi, Fabrice, et al. Anti-HVEM MAb Therapy Improves Antitumoral Immunity Both in Vitro and in Vivo, in a Novel Transgenic Mouse Model Expressing Human HVEM and BTLA Molecules Challenged with HVEM Expressing Tumors. BMJ Publishing Group, 2023.

MLA (9th ed.) Citation

Barlesi, Fabrice, et al. Anti-HVEM MAb Therapy Improves Antitumoral Immunity Both in Vitro and in Vivo, in a Novel Transgenic Mouse Model Expressing Human HVEM and BTLA Molecules Challenged with HVEM Expressing Tumors. BMJ Publishing Group, 2023.